Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

C Reactive Protein Based Early Intervention for Home Quarantined COVID -19 Patients to Avoid Complications and Hospitalization.

NCT04935515 is registered in ClinicalTrials.gov with Manimarane Arjunan, MD,DM (Cardiology) as lead sponsor.

NCT NCT04935515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04935515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
C Reactive Protein Based Early Intervention for Home Quarantined COVID -19 Patients to Avoid Complications and Hospitalization.
Lead sponsor
Manimarane Arjunan, MD,DM (Cardiology)
Phase
Not applicable
Overall status
Completed
Start date
April 15, 2021
Completion date
June 6, 2021
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid -19